HEMORGANIC trading today higher at ₹22.97, an increase of 0% from yesterday's close, completing a monthly increase of 21.4701% or ₹4.06. Over the past 12 months, HEMORGANIC stock gained 36.4014%.
HEMORGANIC is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.